Gracure Pharmaceuticals Limited — Bromhexine Exporter Profile
Indian Pharmaceutical Exporter · #13 for Bromhexine · $254.0K export value · DGFT Verified
Gracure Pharmaceuticals Limited is the #13 Indian exporter of Bromhexine with $254.0K in export value and 18 verified shipments. Gracure Pharmaceuticals Limited holds a 1.6% market share in Bromhexine exports across 2 countries. The company exports 17 pharmaceutical products worth $28.1M across 9 therapeutic categories.
Gracure Pharmaceuticals Limited — Bromhexine Export Profile: Buyers & Destinations
Where Does Gracure Pharmaceuticals Limited Export Bromhexine?
Gracure Pharmaceuticals Limited exports Bromhexine to 2 countries. The largest destination is AUSTRALIA accounting for 93.0% of Gracure Pharmaceuticals Limited's Bromhexine shipments. These destinations reflect Gracure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bromhexine from Gracure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NOUMED PHARMACEUTICALS PTY LTD, | AUSTRALIA | $153.6K | 11 |
| NOUMED PHARMACEUTICALS PTY LIMITED | AUSTRALIA | $54.0K | 4 |
| NOUMED PHARMACEUTICALS PTY LTD | AUSTRALIA | $28.5K | 2 |
| LIGHT OF MERCY CO., LTD. | MYANMAR | $17.9K | 1 |
Gracure Pharmaceuticals Limited supplies Bromhexine to 4 buyers globally. The largest buyer is NOUMED PHARMACEUTICALS PTY LTD, (AUSTRALIA), followed by NOUMED PHARMACEUTICALS PTY LIMITED (AUSTRALIA) and NOUMED PHARMACEUTICALS PTY LTD (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bromhexine Export Value and How Much Does Gracure Pharmaceuticals Limited Contribute?
India exported $10.3M worth of Bromhexine through 1,945 shipments from 288 suppliers to 109 countries, serving 530 buyers globally. Gracure Pharmaceuticals Limited contributes $254.0K to this total, accounting for 1.6% of India's Bromhexine exports. Gracure Pharmaceuticals Limited ships Bromhexine to 2 countries through 4 buyers.
What Is the Average Shipment Value for Gracure Pharmaceuticals Limited's Bromhexine Exports?
Gracure Pharmaceuticals Limited's average Bromhexine shipment value is $14.1K per consignment, based on 18 shipments totaling $254.0K. The largest destination is AUSTRALIA (93.0% of Gracure Pharmaceuticals Limited's Bromhexine exports).
How Does Gracure Pharmaceuticals Limited Compare to Other Indian Bromhexine Exporters?
Gracure Pharmaceuticals Limited ranks #13 among 288 Indian Bromhexine exporters with a 1.6% market share. The top 3 exporters are UMAVIDA PHARMA PRIVATE LIMITED ($2.6M), EMCURE PHARMACEUTICALS LIMITED ($2.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($907.7K). Gracure Pharmaceuticals Limited processed 18 shipments to 2 destination countries.
What Bromhexine Formulations Does Gracure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TERRYWHITE CHEMMART CHESTY COUGH RELIEFFORTE(BROMHEXINE HYDROCHLORIDE 8MG/ 5MLSYRUP)200ML/BTL BATCH NO:AS240052A* | $33.4K | 3 |
| GRASOLVON ( BROMHEXINE HYDROCHLORIDE TABLETS ) 10X10/ BOX (BATCH NO. AT250134A,AT250135A MFG DT. 02/2025 EXP DT.01/2028) | $17.9K | 1 |
| PHARMACY CHOICE MUCOLYTIC CHESTY COUGH FORTEBROMHEXINE HYDROCHLORIDE 8MG/5ML ORAL LIQUID200ML/BTL - (14460 NO.)** | $17.3K | 1 |
| PHARMACY CHOICE MUCOLYTIC CHESTY COUGH FORTE BROMHEXINE HYDROCHLORIDE 8MG/5ML ORAL LIQUID 200ML/BTLBATCH NO:AS240055A* | $17.0K | 1 |
| TERRYWHITE CHEMMART CHESTY COUGH RELIEFFORTE(BROMHEXINE HYDROCHLORIDE 8MG/ 5MLSYRUP) 200ML/BTL BATCH NO:AS230261A* | $16.7K | 1 |
| PHARMACY CHOICE MUCOLYTIC CHESTY COUGH FORTE BROMHEXINE HYDROCHLORIDE 8MG/5ML ORAL LIQUID200ML/BTL BT NO.AS230345A***NOS | $16.7K | 1 |
| PHARMACY HEALTH CHESTY COUGH RELIEF FORTE BROMHEXINE HYDROCHLORIDE 8MG 5ML SYRUP 200ML BTL | $16.4K | 1 |
| TERRYWHITE CHEMMART CHESTY COUGH RELIEFFORTE(BROMHEXINE HYDROCHLORIDE 8MG/ 5MLSYRUP) 200ML/BTL . ** | $16.0K | 1 |
| PRICELINE PHARMACY CHESTY COUGH RELIEF FORTE(BROMHEXINE HYDROCHLORIDE 8MG/ 5ML SYRUP) 200ML/BTL *** | $16.0K | 1 |
| PHARMACY CHOICE MUCOLYTIC CHESTY COUGHBROMHEXINE HYDROCHLORIDE4MG/5ML ORAL LIQB.NO:AS240142A,MF-D.04/2024,EX-D.03/2027 | $13.0K | 1 |
Gracure Pharmaceuticals Limited exports 16 distinct Bromhexine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TERRYWHITE CHEMMART CHESTY COUGH RELIEFFORTE(BROMHEXINE HYDR with 3 shipments worth $33.4K.
Regulatory Requirements: Exporting Bromhexine to Key Markets
What Gracure Pharmaceuticals Limited must comply with to export Bromhexine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gracure Pharmaceuticals Limited Compare to Nearest Bromhexine Exporters?
Exporters ranked immediately above and below #13 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | LABORATE PHARMACEUTICALS INDIA LTD | $287.8K | 12 | 3 | $24.0K |
| 12 | ADCOCK INGRAM LIMITED | $269.6K | 16 | 2 | $16.9K |
| 13 | GRACURE PHARMACEUTICALS LIMITED ★ | $254.0K | 18 | 2 | $14.1K |
| 14 | S.D.PHARMACEUTICALS | $225.0K | 17 | 1 | $13.2K |
| 15 | BAROQUE PHARMACEUTICALS PVT LTD | $218.0K | 13 | 1 | $16.8K |
Gracure Pharmaceuticals Limited ranks #13 among 288 Indian Bromhexine exporters. Average shipment value of $14.1K compared to the market average of $35.7K. The closest competitors by value are LABORATE PHARMACEUTICALS INDIA LTD and ADCOCK INGRAM LIMITED.
Which Indian Ports Ship Bromhexine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 303 | 15.6% |
| JNPT | 169 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 164 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 157 | 8.1% |
| AHEMDABAD ICD | 74 | 3.8% |
| SAHAR AIR | 73 | 3.8% |
| AHEMDABAD AIR ACC (INAMD4) | 72 | 3.7% |
| AHEMDABAD ICD (INSBI6) | 59 | 3.0% |
What Other Respiratory & OTC Products Does Gracure Pharmaceuticals Limited Export?
Gracure Pharmaceuticals Limited also exports these respiratory & otc products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gracure Pharmaceuticals Limited's Bromhexine Exports
Recent geopolitical tensions, particularly in the Middle East, have significantly impacted global shipping routes. The Red Sea crisis and Houthi attacks have led to increased shipping costs and extended transit times for Indian exporters. Major carriers have suspended or restricted transits through the Red Sea–Suez Canal corridor, resulting in transit times extending by 10–20 days and freight rates rising by 40–50% on key India–Europe routes. (livemint.com)
For Gracure Pharmaceuticals, which relies heavily on maritime routes for its exports, these disruptions pose challenges in maintaining timely deliveries and managing increased operational costs. Additionally, the U.S.–India diplomatic and trade crisis, marked by the imposition of tariffs on Indian exports, further complicates the export landscape. The U.S. administration imposed a 25% "reciprocal" tariff, followed by an additional 25% penalty tied to India's continued imports of Russian oil, bringing the total duty to 50%. (en.wikipedia.org) These developments necessitate strategic adjustments to mitigate potential revenue losses and sustain market competitiveness.
Gracure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Gracure Pharmaceuticals has secured approvals and clearances from various international regulatory bodies, reflecting its commitment to quality and safety. However, evolving regulations, such as the European Union's falsified medicines directive, impose additional compliance requirements. Adhering to these standards is crucial for maintaining market access and consumer trust.
Furthermore, the U.S. Food and Drug Administration (FDA) has intensified scrutiny of foreign pharmaceutical manufacturers. Ensuring compliance with FDA regulations is essential for Gracure to sustain and expand its presence in the lucrative U.S. market.
About Gracure Pharmaceuticals Limited
Gracure Pharmaceuticals Limited exports 17 products worth $28.1M. Beyond Bromhexine, top products include Tramadol, Albendazole, Folic, Melatonin, Celecoxib. View the complete Gracure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bromhexine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bromhexine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gracure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 18 individual customs records matching Gracure Pharmaceuticals Limited exporting Bromhexine, covering 16 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 530+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bromhexine Export Data from Gracure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gracure Pharmaceuticals Limited's Bromhexine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gracure Pharmaceuticals Limited
Full Company Profile →
17 products · $28.1M total trade · 9 categories
Bromhexine Stats
Company Overview
Top Products by Gracure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gracure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bromhexine. For current shipment-level data, contact TransData Nexus.